1540 results for Leukemia
Refine Your Search
Study from The Leukemia & Lymphoma Society Provides New Information on How Blood Cancer Patients Respond to COVID-19 Vaccines
A new study from The Leukemia & Lymphoma Society reports that blood cancer patients who do not produce detectable antibodies after vaccination may ha…
Subaru Celebrates Ten Years Partnering with The Leukemia & Lymphoma Society
Subaru Celebrates Ten Years Partnering with The Leukemia & Lymphoma Society To Support Nearly , Cancer Patients and Families NationwideAutomaker provi…
News Release
FDA Approves New Treatment for Adults with Chronic Myeloid Leukemia
Asciminib provides another option to help CML patients live longer, healthier lives Rye Brook, N.Y., December , – The U.S. Food and Drug Administrati…
News Release
Cotargeting oncogenic protein translation and apoptosis in acute myeloid leukemia
The focus of my research is to evaluate the efficacy of and to unravel the molecular mechanisms underpinning a novel drug combination in AML targeting…
Functionalizing novel PHIP variants in ancestry specific Acute Myeloid Leukemia
AML risk stratification established by previous studies do not reflect survival outcomes observed in Black patients. Exome sequencing of Black AML pa…
Niclosamide for the treatment of relapsed pediatric acute myeloid leukemia
Niclosamide is an FDA approved drug that is well tolerated in adults and children. AML cells are sensitive to niclosamide, act synergistically with c…
SHP2 and BCL2 Inhibition in Acute Myeloid Leukemia
The goal of our work is to use a “bench to bedside and back” approach to develop new treatments for patients with relapsed/refractory AML. Through gen…
The Impact of Minimal Residual Disease in Acute Lymphoblastic Leukemia
[Click here to enlarge.] Presentation Click Here Topics Covered We invite you to learn more about: …
The Leukemia & Lymphoma Society Applauds Therapy Advances for Myeloma Patients
For Immediate ReleaseContact: Andrea GreifSenior Director of Communications()- (p))- (c)[email protected](White Plains, NY) - February , - Two re…
News Release
2012 Leukemia Ball Toasts 25 Years of Making a Difference
Leukemia Ball Toasts Years of Making a Difference Silver Anniversary Gala to Feature Performances by Classic Rock Band Foreigner and …
Improving therapy for CRLF2-rearranged Ph-like acute lymphoblastic leukemia
CRLF2-rearranged ALL is the most common subset of ALL, has a very poor prognosis and lacks effective therapy. This project will use two novel approac…
Niclosamide for the Treatment of Relapsed/Refractory Pediatric Acute Myeloid Leukemia
Niclosamide is an FDA approved drug that is well tolerated and acts synergistically with chemotherapy to kill AML cells. We will conduct a Phase I cl…
UCLA Health Joins The Leukemia & Lymphoma Society’s Innovative Clinical Trial
The Beat AML Master Clinical Trial is a collaboration to bring precision medicine to patients with acute myeloid leukemia and is the first clinical …
New Series-Research Highlight: Acute Lymphoblastic Leukemia-New Targets, Pathways and Therapies
LLS Community is launching a new series focused on highlighting research in blood cancer. The first in this series focuses on Acute Lymphoblastic Leuk…
LLS Announced a Collaboration with the National Cancer Institute and Children’s Oncology Group on a Global Master Clinical Trial for Children with Acute Leukemia
The Leukemia & Lymphoma Society (LLS) announced today a collaboration with the National Cancer Institute (NCI) and the Children’s Oncology Group (COG)…
BioInvent Selected to The Leukemia & Lymphoma Society’s Therapy Acceleration Program and Receives $3 Million Strategic Equity Investment
Lund, Sweden – January , – BioInvent International AB (“BioInvent”) (Nasdaq Stockholm: BINV), a biotech company focused on the discovery and developm…
Oral Formulation of Methotrexate Now Available for Children with Leukemia Subtype
New formulation of key blood cancer treatment offers important option for children, may help with ongoing cancer drug shortages Rye Brook, N.Y., Decem…
The Leukemia & Lymphoma Society Denounces Federal Actions that Threaten Cancer Patients
WASHINGTON, February , – As the nation’s largest organization serving the critical needs of blood cancer patients, we are alarmed by recent actions t…
News Release
The Leukemia & Lymphoma Society Welcomes Five Members to Board of Directors
(Rye Brook, NY, July , ) - The Leukemia & Lymphoma Society (LLS) announced five new members to its board of directors effective July , : Leroy M. Ball…
News Release
Therapeutic exploitation of novel mouse models and metabolic interventions in leukemia
Our research program aims to gain a deeper understanding of the pathobiology of and HSTL.To this end, we will use novel mouse models, techniques and…
The Leukemia & Lymphoma Society Kicks Off Light The Night Fall Campaign
(Los Angeles, CA July , ) – The Leukemia & Lymphoma Society’s (LLS) California Southland Chapter celebrated its Light The Night® with a event and aw…
The Leukemia & Lymphoma Society Makes Fast Company’s Fifth Annual List of the Best Workplaces for Innovators in Nonprofit Category
The Leukemia & Lymphoma Society Makes Fast Company’s Fifth Annual List of the Best Workplaces for Innovators in Nonprofit Category
News Release